Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Amyotrophic lateral sclerosis and Herb, with related work in Myasthenia gravis, Fasciculation, Immunohistochemistry. Notable publications include 'S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis', 'trans-Polydatin protects the mouse heart against ischemia/reperfusion injury via inhibition of the renin–angiotensin system (RAS) and Rho kinase (ROCK) activity', and 'Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis'.
Application of Antimicrobial Peptides in Wound Dressings
Modified Gegen Qinlian Decoction Ameliorates DSS‐Induced Colitis in Mice via the Modulation of NF‐ <i>κ</i> B and Nrf2/HO‐1 Pathways
Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis
Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG
S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis
Fasciculation score: a sensitive biomarker in amyotrophic lateral sclerosis
Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis
Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma
Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis
trans-Polydatin protects the mouse heart against ischemia/reperfusion injury via inhibition of the renin–angiotensin system (RAS) and Rho kinase (ROCK) activity